Generic name |
tofacitinib |
---|---|
Strength |
5 mg, 11 mg |
Form |
tablet and extended-release tablet |
Special Authority criteria |
Approval period |
---|---|
For the treatment of rheumatoid arthritis when tofacitinib is prescribed by a rheumatologist according to established criteria, as noted in eForms submission (and on the Special Authority forms linked below). Tofacitinib is to be used in combination with methotrexate, or without methotrexate in patients who are intolerant to methotrexate |
First approval: 1 year Renewal: 1 year or indefinite |